Chung Iu
President at Shanghai Mingyuan Enterprise Group Co. Ltd.
Chung Iu active positions
Companies | Position | Start | End |
---|---|---|---|
HD Global Ltd.
HD Global Ltd. Pharmaceuticals: MajorHealth Technology Part of Mingyuan Medicare Development Co. Ltd., HD Global Ltd. is a Chinese company that researches, develops, and commercializes proteomic products. The company is based in Huzhou, China. HD Global was acquired by Mingyuan Medicare Development Co. Ltd. on July 16, 2003 for $9.81 million. | Director/Board Member | 18/03/2010 | - |
Shanghai Mingyuan Enterprise Group Co. Ltd. | Director/Board Member | 14/09/2011 | - |
President | 18/03/2010 | - |
Career history of Chung Iu
Former positions of Chung Iu
Companies | Position | Start | End |
---|---|---|---|
MINGYUAN MEDICARE DEVELOPMENT CO., LTD. | Director/Board Member | 26/03/2007 | 14/02/2011 |
Statistics
International
China | 3 |
Hong Kong | 2 |
Operational
Director/Board Member | 3 |
President | 1 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
Mingyuan Medicare Development Co. Ltd.
Mingyuan Medicare Development Co. Ltd. BiotechnologyHealth Technology Mingyuan Medicare Development Co. Ltd. engages in provision of medicare solutions for the early detection and prevention of diseases particularly in China. It operates through the following segments: Protein Chips, Healthcare, Medical Centers Management, Individualized Target Therapy, and Bio-Drugs. The Protein Chips segment manufactures and distributes C-12 products to hospitals, medical centers, and life insurance companies in China. The Healthcare segment engages in the provision of sales and marketing campaign for HPV DNA testing kits and making important progress to register products for distribution to female patients at hospitals nationwide. The Medical Centers Management segment engages in the provision of healthcare services for residents living in cities. The Individualized Target Therapy segment specializes in molecular diagnostic kits for leukemia, lymphoma and individualised target cancer therapy. The Bio-Drugs segment engages in the development, production and commercialization of a new generation of non-specific nanotechnology immunomodulatory drugs known as non-cell Corynebacterium pavum products. The company was founded on May 8, 1989 and is headquartered in Hong Kong. | Health Technology |
HD Global Ltd.
HD Global Ltd. Pharmaceuticals: MajorHealth Technology Part of Mingyuan Medicare Development Co. Ltd., HD Global Ltd. is a Chinese company that researches, develops, and commercializes proteomic products. The company is based in Huzhou, China. HD Global was acquired by Mingyuan Medicare Development Co. Ltd. on July 16, 2003 for $9.81 million. | Health Technology |
Shanghai Mingyuan Enterprise Group Co. Ltd. |
- Stock Market
- Insiders
- Chung Iu
- Experience